Gastroenterology
News from the FDA/CDC
FDA approves first treatment for constipation in children
SBM frequency improved during the first week and was maintained throughout the remainder of the 12-week treatment period.
Livin' on the MDedge
The enemy of carcinogenic fumes is my friendly begonia
Also: Driving the gastrointestinal highway and pulling the plug on an unsupervised chatbot.
From the Journals
New guideline weighs medication options for chronic constipation
Evidence for a range of prescription and over-the-counter therapies, along with specific recommendations for implementing them, are laid out in a...
From the Journals
Sucralose damages DNA, linked to leaky gut: Study
The FDA says sucralose is safe, describing it as 600 times sweeter than table sugar and used in “baked goods, beverages, chewing gum, gelatins,...
Latest News
APA launches online eating disorder assessment tool
The tool guides clinicians through the screening, assessing, diagnosing, and treatment planning of patients with anorexia nervosa, bulimia nervosa...
Feature
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how...
Conference Coverage
AxSpA remission on TNFi seen in half of patients with comorbid IBD
Those who had IBD for less than 5 years and those taking adalimumab, as opposed to another TNFi, had higher likelihood of reaching axSpA remission...
News from the FDA/CDC
FDA approves Yuflyma as ninth adalimumab biosimilar
The manufacturer Celltrion is also seeking an interchangeability designation from the FDA, tentatively expected in the fourth quarter of 2024.
News from the FDA/CDC
FDA approves autoinjector pen for Humira biosimilar, Cyltezo
The drug will be commercially available on July 1, 2023.
From the Journals
Study explains link between fatty liver and CRC liver metastasis
Findings of a new study suggest that CRC patients with nonalcoholic fatty liver disease may respond differently to treatment than those without...
From the Journals
How BMI over time impacts GI cancer risk
These “important findings highlight the unmet need to identify the critical time window linking adiposity and GI cancer.”